Praliciguat and Soluble Guanylate Cyclase Stimulators for Peripheral Artery Disease

Kate Kosmac; Ahmed Ismaeel; Daniel B. Kim-Shapiro; Mary M. McDermott

doi:10.1161/CIRCRESAHA.122.322298

Praliciguat and Soluble Guanylate Cyclase Stimulators for Peripheral Artery Disease

Kate Kosmac, Ahmed Ismaeel, Daniel B. Kim-Shapiro, Mary M. McDermott

Research output: Contribution to journal › Editorial

Original language	English
Pages (from-to)	49-51
Number of pages	3
Journal	Circulation Research
Volume	132
Issue number	1
DOIs	https://doi.org/10.1161/CIRCRESAHA.122.322298
State	Published - Jan 6 2023

Bibliographical note

Funding Information:
M.M. McDermott reports funding from the National Institute on Aging, National Heart Lung Blood Institute, American Heart Association, and Helixmith. She also reports other research support from ArtAssist, Mars, Helixmith, Chromadex, ReserveAge.

Funding Information:
M.M. McDermott reports funding from the National Institute on Aging, National Heart Lung Blood Institute, American Heart Association, and Helixmith. She also reports other research support from ArtAssist, Mars, Helixmith, Chromadex, ReserveAge.

Keywords

cilostazol
disability
Editorials
nitric oxide
peripheral artery disease
revascularization
therapeutics

ASJC Scopus subject areas

Physiology
Cardiology and Cardiovascular Medicine

Access to Document

10.1161/CIRCRESAHA.122.322298

Cite this

@article{7f573e03f6db452e9b1c03363346b935,

title = "Praliciguat and Soluble Guanylate Cyclase Stimulators for Peripheral Artery Disease",

keywords = "cilostazol, disability, Editorials, nitric oxide, peripheral artery disease, revascularization, therapeutics",

author = "Kate Kosmac and Ahmed Ismaeel and Kim-Shapiro, {Daniel B.} and McDermott, {Mary M.}",

note = "Funding Information: M.M. McDermott reports funding from the National Institute on Aging, National Heart Lung Blood Institute, American Heart Association, and Helixmith. She also reports other research support from ArtAssist, Mars, Helixmith, Chromadex, ReserveAge. Funding Information: M.M. McDermott reports funding from the National Institute on Aging, National Heart Lung Blood Institute, American Heart Association, and Helixmith. She also reports other research support from ArtAssist, Mars, Helixmith, Chromadex, ReserveAge. ",

year = "2023",

month = jan,

day = "6",

doi = "10.1161/CIRCRESAHA.122.322298",

language = "English",

volume = "132",

pages = "49--51",

number = "1",

}

TY - JOUR

T1 - Praliciguat and Soluble Guanylate Cyclase Stimulators for Peripheral Artery Disease

AU - Kosmac, Kate

AU - Ismaeel, Ahmed

AU - Kim-Shapiro, Daniel B.

AU - McDermott, Mary M.

N1 - Funding Information: M.M. McDermott reports funding from the National Institute on Aging, National Heart Lung Blood Institute, American Heart Association, and Helixmith. She also reports other research support from ArtAssist, Mars, Helixmith, Chromadex, ReserveAge. Funding Information: M.M. McDermott reports funding from the National Institute on Aging, National Heart Lung Blood Institute, American Heart Association, and Helixmith. She also reports other research support from ArtAssist, Mars, Helixmith, Chromadex, ReserveAge.

PY - 2023/1/6

Y1 - 2023/1/6

KW - cilostazol

KW - disability

KW - Editorials

KW - nitric oxide

KW - peripheral artery disease

KW - revascularization

KW - therapeutics

UR - http://www.scopus.com/inward/record.url?scp=85145645322&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85145645322&partnerID=8YFLogxK

U2 - 10.1161/CIRCRESAHA.122.322298

DO - 10.1161/CIRCRESAHA.122.322298

M3 - Editorial

C2 - 36603062

AN - SCOPUS:85145645322

VL - 132

SP - 49

EP - 51

IS - 1

ER -

Praliciguat and Soluble Guanylate Cyclase Stimulators for Peripheral Artery Disease

Bibliographical note

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this